As of 2026-04-03, the EV/EBITDA ratio of Eiger BioPharmaceuticals Inc (EIGR) is -0.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EIGR's latest enterprise value is 18.71 mil USD. EIGR's TTM EBITDA according to its financial statements is -71.42 mil USD. Dividing these 2 quantities gives us the above EIGR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 16.7x | 14.5x |
| Forward P/E multiples | 17.7x - 21.0x | 19.7x |
| Fair Price | (3,589.59) - (3,377.49) | (3,465.54) |
| Upside | -42330.5% - -39835.2% | -40871.0% |
| Date | EV/EBITDA |